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Abstract 
Health expenditure in Sub-Saharan Africa (SSA) has improved over the years with several recent 
efforts to improve resource commitments to the health sector. Health outcomes in the region 
have, however, seen little improvements over the years. Several reasons, including the efficiency 
of health expenditure, have been given to justify this mismatch. Studies on health expenditure 
efficiency have mainly focused on developed regions with little attention to SSA. The objective 
of the study was, therefore, to examine The effects of corruption and public institution quality on 
efficiency. The efficiency of health expenditure was also compared across selected SSA 
countries. Data for the study was sourced from the World Bank's World Development Indicators 
for 45 countries covering the period 2005 to 2011. The two-stage Data Envelopment Analysis 
(DEA) was employed for the analysis. The first stage computes efficiency scores while the 
second stage examines the determinants of efficiency using the Tobit model. Per capita health 
expenditure was used as input while infant, under-five mortality and crude death rates were used 
as outputs. The results show that health expenditure efficiency was low with average scores of 
approximately 0.5. This suggests that there exist significant potential for SSA countries to 
improve population health outcomes given the level of expenditure. There was significant 
variation across countries with Cape Verde, Eritrea and Mauritius among the efficient countries 
while Equatorial Guinea, Sierra Leone and Swaziland were relatively inefficient. High 
corruption and poor public sector institutions reduced health expenditure efficiency. The findings 
emphasize the fact that, while increased health spending is necessary, it is also important to 
ensure efficiency in resource use across SSA countries. This can be achieved by effective 
monitoring and evaluation programmes that ensure reduced corruption and improved public 
institutions.   
Keywords: Health expenditure efficiency, Tobit model, DEA, SSA, Corruption, Public 
institutions 
JEL classification: C50, C67, I10, I12  
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1.1 Introduction 
Sub-Saharan African countries have been identified to be less efficient in the use of health 
resources. The World Health Report of 2000 showed that countries in developing regions (like 
SSA) possess significant potential to improve health status if resources are used in an efficient 
way. With SSA facing high disease burdens and poor performance in terms of health status, the 
potential benefits of an efficient health system cannot be over emphasised.  
The Africa region lags behind in achieving the health-related MDG targets with most countries 
in the region unlikely to achieve these targets. HIV/AIDS, malaria and tuberculosis remain the 
major causes of mortality and morbidity in the region with estimated incidence of 217; 21,537 
and 276; per 100,000 population, respectively in 2009 (WHO, 2012). The WHO in 2011 also 
showed that only eight countries were on track to achieve the health related MDGs. Majority of 
the countries in the region were achieving less than 50% of what is expected to reach the target 
in 2015, with progress on MDG 5 (maternal mortality) being particularly slow. 
Adequate and sustained levels of health resources is often identified as the biggest constraint to 
achieving improved health outcomes and economic growth in general (Tandon and Cashin, 
2010). The Abuja declaration of 2001 was intended to improve health expenditure in public 
budgets in SSA with the aim of improving health. However very few countries in the region are 
close to the target of 15% of government budget (Tandon and Cashin, 2010).  
Improving this situation requires a comprehensive analysis of health systems in the region with 
regards to the efficiency in the use of resources (Powell-Jackson et al., 2012). For instance the 
WHO (2012) noted that high or low levels of health funding might not translate into improved 
health outcomes but rather efficiency and equity in the use of these resources. The purpose of 
this study, therefore, was to evaluate the efficiency of health expenditure as well as the effects of 
corruption and public institutions on health expenditure efficiency. 
2.1 Overview of Health systems in SSA 
Before the global economic meltdown in 2007/2008, efforts towards the improvement of health 
in SSA received much attention from the international community with funding to combat health 
problems which kept rising steadily. Evidence of improved health was recorded in some 
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countries like Uganda and Tanzania (Bryan et al., 2010). In spite of this progress, many other 
countries in the region have struggled to show improvement in health status with diseases such 
as Malaria, HIV/AIDS and Tuberculosis still having devastating effects on the population in 
SSA. This has led to a call to improve the health systems in SSA countries by ensuring efficiency 
in public health expenditure.  
The world economic outlook report argues that majority of the health problems facing SSA could 
be avoided with a well functioning, efficient and effective health care system (Neelam, 2007). 
Indeed, questions about who pays for health, how much do they pay, where is money spent, who 
delivers health services and how good are services delivered, characterize the performance of the 
health system in SSA. While there has been recent calls to increase resources devoted to the 
health sector, the efficiency in using the existing resources have been over-looked. The relatively 
low levels of health expenditure underscores the need for understanding health expenditure 
efficiency in the region 
The pattern and trend in the performance of health care expenditure across regions of the world 
and the world average show that, relative to all other regions of the world (with the exception of 
MENA), SSA spends the lowest on health as percentage of Gross Domestic Product (GDP). 
Total health expenditure as percent of GDP increased in SSA from 5.9 in 2000 to 6.4 in 2011, 
relative to the world average of 9.2 to 10.1, North America (from 13.1 to 17.1), OECD (from 
10.0 to 12.3), MENA (from 4.6 to 4.8) and EAP (from 6.6 to 6.8).  
Further, public health expenditure as percent of GDP in 2011 was 2.9% for SSA relative to the 
world average (6.0%), North America (8.2%), East Asia and Pacific (4.6%). Similarly, private 
health expenditure as percentage of GDP was 3.6% for SSA, which suggests poor performance 
against the world average (4.1%), East Asia and Pacific (2.2%) and North America (9.0%) in 
2011. This suggests that health related expenditures still remain major concerns in developing 
regions like SSA (Table 2.1). It is worth noting that, relative to other regions of the world, only 
SSA and North America has private health expenditure as percentage of GDP higher than public 
health expenditure. All other regions have greater share of their public health expenditure 
sources relative to private sources. 
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Moreover, SSA remains one of the most burdened regions in terms of communicable and non-
communicable diseases and health in general. This explains the significantly high maternal and 
child mortality rates as well as crude death rates in the region, relative to all other regions in the 
world. It is reported that communicable diseases alone accounted for about 798 age-standardized 
deaths per 100,000 population in 2008. Similarly, non-communicable diseases accounted for 779 
deaths per 100,000 population. These statistics are above the global average 230 and 573 deaths 
per 100, 000 population caused by communicable and non-communicable diseases respectively 
(WHO, 2013).  
Mortality among children in the region are mainly caused by Diarrhoea (11% in 2010), Malaria 
(15% in 2010) and Pneumonia (17% in 2010). In the case of adults, the highest ranked causes of 
death in the SSA region include HIV/AIDS (139 deaths per 100,000 population 2011), malaria 
(72 deaths per 100,000 population in 2010) and tuberculosis (26 deaths per 100,000 population 
in 2011). These statistics are higher than the world average and any other region of the world 
(WHO, 2013).  
In addition to the high disease burden in the SSA region, the region also lacks health workforce 
and infrastructure necessary to improve the health status of the population. The region is faced 
with the problem of "brain drain", where trained health workforce leave for greener countries in 
other developed regions of the world. Between 2005 and 2012, an average of 2.5 physicians and 
9.1 nurses/midwifery personnel per 10,000 population were recorded in the SSA region. These 
statistics significantly fall short of the world average of 13.9 physicians and 29.0 
nurses/midwifery personnel per 10,000 population. 
3.0 Theoretical Literature 
3.1 Health Production Function 
The first attempt to conceptualize health capital and investment is credited to Grossman (1972). 
The theoretical formulation of Grossman provides a micro-level insight into the investment made 
by individuals to improve their stock of health as it depreciates over time. It is worth noting that 
earlier studies provided theoretical insight into investment in human capital in general. For 
instance Becker (1967) and Ben-Porath (1967) developed models that determine the optimal 
quantity of investment in human capital. Other studies have considered health as any other form 
5 
 
of human capital and argued that the model on investment in human capital could also be applied 
to health capital (Mushkin, 1962, Becker, 1964, Fuchs, 1966). 
Grossman (1972) provided a contrary argument that health capital is unique and should be 
distinguished from any other form of human capital. The main point of departure from previous 
theoretical attempts on human capital is that while other forms of human capital
2
 directly affects 
market and non-market productivity, health capital influences the total amount of time available 
to engage in these market and non-market activities. For instance, one's knowledge of an 
economic activity will influence how much of output from that activity can be produced. 
However, the individual's health status determines how much time the individual can spend 
producing. This implies that even though the individual has the knowledge to produce more, this 
may be limited by the poor health of the individual.  
The relevance of the Grossman model in the current study lies in the proposition that individuals 
inherit an initial stock of health that depreciates over time but can be increased by investments in 
health. Gross investments in health capital are produced by production functions whose direct 
inputs include the time of the individual and other market goods such as medical care, diet, 
exercise, recreation and housing. The amount spent on these market goods directed to improve 
the stock of  health may be considered as health care expenditure. Aside the consumer's time and 
market goods, other environmental factors may influence the production function. The education 
of the producer is considered to be the most important environmental variable and also relevant 
to the efficiency of the production process. 
If the production of health is considered as a shared responsibility between individuals and 
government, then the model by Grossman can be extended to the macro level by considering the 
entire health system as a production process where inputs are converted into outputs. In this case 
the outputs are the population health status which represents the end result of an efficient use of 
health inputs. Like the micro level, health inputs at the macro level include the use of various 
market goods such as provision of hospitals and equipments needed in the hospital, improved 
sanitation and water supply, improved working conditions, mass media communications on 
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health and various forms of preventive and curative interventions. While these market goods may 
be difficult to identify the level of expenditure can be used to capture health inputs into the 
health system at any point in time. 
In a similar theoretical presentation Wagstaff (1986) used the concept of health production 
function to express the notion that individuals can control their health through their influence on 
health affecting consumption patterns, their health care utilization and their environment. At the 
macro level, this can be conceptualized as the government influencing the health of the 
population through investments in these variables. Wagstaff (1986) argues that just like the case 
in any firm where production functions are seen as a process where outputs are produced by 
combining factor inputs, individuals also produce health by combining health inputs. Similarly at 
the macro level, population health can be improved by effective and efficient combination of 
health inputs. The production process therefore simply links health inputs to the output, health.  
3.3 Empirical Evidence 
Empirical evidence on efficiency in the health economics literature have, over the years, 
concentrated on various components of the health system. These studies are micro based and 
mostly answer the question of how health inputs are used to generate the highest possible 
outcomes within specific components of the health system. In SSA, most of these micro-based 
studies have been at the hospital level (Kirigia et al., 2010, Tlotlego et al., 2010). In a typical 
setting, such studies that estimate efficiency at the hospital level use hospital workforce 
(including physicians and nurses population) and hospital beds as inputs and inpatient and 
outpatient days as health outcomes. 
Another set of studies have analysed efficiency at the disease level. The import of such studies is 
basically to estimate the efficiency in the use of health resources in the prevention and treatment 
of diseases. Such empirical analysis have been done within and across countries (Baily et al., 
1997, Garber and Skinner, 2008). Inputs used in such studies include among others labour 
(physicians, nurses and technicians), supplies (medications, surgical instruments and X-ray 
films) and capital (diagnostic equipments and hospital facilities). Survival rates or quality of life 
with respect to each disease treatment may be used as outcome variables. 
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In much more recent years, the attention of empirical studies on efficiency in the health 
economics literature have been on the health system as a whole. This type of macro level 
analysis of how health resources are used to generate population health outcomes is fast gaining 
grounds. Unlike the micro based studies on efficiency, health care expenditure per capita has 
been widely used as the input variable (WHO, 2000, Afonso and Aubyn, 2005). A few studies 
have, however, exclusively used physical inputs (including population of physicians, nurses and 
hospital beds) at the macro level (Bhat, 2005). Life expectancy, infant, under five and maternal 
mortality rates as well as child survival rates and disability adjusted life years (DALY) have been 
widely used as measures of health system output. 
The pioneering attempt to estimate cross country health expenditure efficiency is credited to the 
World Health Report published in the year 2000. The report provided estimates of health system 
performance for 191 member states of the WHO. Following this, several other studies have 
emerged using various methods and data to estimate the efficiency of health expenditure across 
countries. Majority of the studies focused on OECD countries using the Data Envelopment 
Analysis (DEA) approach and showed evidence of some level of inefficiency in health 
expenditure with significant variations across countries (Hernandez de Cos and Moral-Benito, 
2011, Kotzian, 2009, Bhat, 2005, Afonso and Aubyn, 2005)  
A few other studies progressed to the second stage to identify factors that are responsible for 
health expenditure efficiency. The Tobit model was mostly used with variables within and out of 
the health sector being considered (Kotzian, 2009). Specifically, variables that have been found 
to be significant determinants of health expenditure efficiency include physician salary and 
reimbursement structure (Bhat, 2005); inadequate cost recovery, weaknesses in the financing 
mechanism, institutional arrangements and weaknesses in targeting public subsidies on health 
care (Jafarov and Gunnarsson, 2008 ); civil unrest and the prevalence of HIV and AIDS (Evans 
et al., 2001, Herrera and Pang, 2005); health expenditure, nutrition and female education 
(Alexander et al., 2003, Gupta and Verhoeven, 2001). 
Majority of these studies have focused on developed countries, mainly OECD countries with 
very little attention on developing countries such as SSA. A critical contribution will be to fill 
8 
 
this gab and to identify policy variables that potentially pose significant challenges to health 
systems in the SSA region.  
4.0 Methodology 
4.1 Formulation of the DEA model 
The study employed the two-stage DEA model to examine the effectiveness with which public 
health expenditure are used to generate population health outcomes across SSA countries. In the 
first stage, the extent to which a country could achieve better health for its population if all health 
expenditure were used efficiently was estimated and compared across. The Tobit model was used 
to examine the role of corruption and public sector institutions in influencing efficiency of health 
expenditure. The empirical methods employed in this study follow Fare et al. (1994) and 
Alexander et al. (2003) using non-parametric linear programming techniques. 
The empirical analysis starts by finding out the achievable population health outcome of a 
particular country, given its expenditure on health. This optimization problem is solved by 
constructing a 'best practice' frontier, which is a piece-wise linear envelopment of the health 
expenditure-health outcome data for the sample countries. The estimated frontier describes the 
most efficient performance conditions within the countries and therefore forms a benchmark for 
comparison.  
Efficiency in the production of population health is measured relative to such a frontier for each 
country. The health systems of countries that are operating on (and determine) the frontier are 
termed efficient while countries with health systems operating off the frontier are considered to 
be relatively inefficient. Inefficiency in this case should be understood to mean that better 
population health outcomes could be attained from the observed health expenditure, were 
performance similar to that of 'best-practice' countries (Alexander et al., 2003). 
To better understand the procedures described above, let S
t
 be the technology that transforms 
health sector expenditure into population health outcomes. This technology can be modelled by 
the output possibility set 
 ( ) : ( , ) 1,...,t t t t t tP x y x y S t T           (1) 
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where P
t
(x
t
) denotes the collection of population health output vectors that consume no more that 
the bundle of resources indicated by the resource vector x
t
, during period t. 
The best practice frontier can be empirically estimated as the upper bound of the output 
possibility set, P
t
(x
t
). The output possibility set, P
t
(x
t
), can be estimated empirically by assuming 
that the sample set is made up of observations on j=1,...J countries' health systems, each using 
n=1,...N resources, 
t
jnx , during period t, to generate m=1,...,M population health outcomes, 
t
jmy , 
in period t. Accordingly, P
t
(x
t
) is estimated from the observed set of health expenditures, and 
population health outcomes for all the countries of the sample. 
The empirical construction of the piece-wise linear envelopment of the input possibility set is 
given by 
1
1
1
( ) { : , 1,...,
, 1,...,
1
0, 1,..., }
J
t t t t t
n j jn
j
J
t t
j jm m
j
J
j
j
j
P x y x z x n N
z y y m M
z
z j J



  
 

 



       (2)        
where zj is a variable indicating the weighting of each of the health systems. 
The output-based efficiency score for each country's health system for period t can be derived as 
( , )t t to j iF x y = max{θ such that θy
t
 ϵ Pt(xt)} where ( , ) 1t t to j iF x y  .    (3) 
This suggests that a county's health outcomes vector, y
t
, will be located on the efficiency frontier 
when equation (3) has a value of one. However, if equation (3) produces a value less than one, 
the health system must be classified as inefficient relative to best-observed practice. This 
measure can be computed for country j as the solution to the linear programming problem 
( , ) maxt t to j iF x y            (4) 
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with θ, z such that 
1
1
1
, 1,..., ,
, 1,..., ,
1,
0, ,..., ,
J
t t
j jm jm
j
J
t t
j jn jn
j
J
j
j
j
z y y m M
z x x n N
z
z j J




 
 

 



        (5) 
where the restrictions on the weighting variables, zj, imply a variable returns to scale assumption 
in regard to the underlying technology of health production.  
4.2 Choice of inputs and outputs      
Health expenditure per capita expressed in purchasing power parity terms was used input. 
Following theory and common practice in the literature, the current study employed education 
(measured by average years of schooling) as indirect health input variable which, even though, 
not directly controlled by the health system, is highly likely to influence health status (Caldwell 
and Caldwell, 1985). 
Life expectancy at birth, infant and under-five mortality and crude death rates were used as 
health outputs. However, as noted by Afonso and Aubyn (2005), efficiency measurement 
techniques suggest that outputs are measured in such a way that "more is better". Therefore 
consistent with practice in the literature, various transformations were performed on the 
mortality variables so that they are measured in survival rates. For instance, infant mortality rate 
(IMR) is measured as [(number of children who died before 12 months)/(number of children 
born)] X 1000. This implies that an infant survival rate (ISR) can be computed as follows; 
1000 IMR
ISR
IMR

           (6) 
This shows the ratio of children that survived the first year to the number of children that died 
and this increases with better health status. Similar transformations were performed for the other 
mortality variables.  
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4.3 Determinants of health expenditure efficiency 
A Tobit model was used to estimate the relationship between dependent variable yi (efficiency 
scores) and a vector of explanatory variables xi (McDonald, 2009). For the ith Decision Making 
Unit (DMU), the Tobit model can be defined as follows: 
*
i i iy x               (7) 
If Yi
*
 ≤ 0, Yi=0; If Yi
*
 ≥ 1, Yi=1 and if 0<Yi
*
<1, Yi=Yi
*
 
Where yi
*
 is an unobservable latent variable, εi is normally, identically and independently 
distributed with zero mean and variance, σ2. xi is a vector of explanatory variables and β, a vector 
of unknown coefficients.  
The following reduced-form equations were specified for the purposes of estimation. 
1 2 3 4 5 6 7Imit i it it it it it it
n nit it
n
ineff Corrupt PuHE Y m S HIV U
Pop
       
 
       
 
 (8) 
1 2 3 4 5 6 7Imit i it it it it it it
n nit it
n
ineff Inst PuHE Y m S HIV U
Pop
       
 
       
 
 (9) 
Where i and t represent country and time, respectively, while n represents different population 
brackets in terms of the explanatory variables. A detailed description of the variables are 
presented in Table 1 below. 
Table 1: Variable description and data source 
Variables Description Data source 
Public health care 
expenditure 
(PuHE) 
Level of public spending on health expressed as percent of GDP. 
Includes spending from government budgets, external borrowing, 
grants and social health insurance funds 
WDI 
Real GDP per 
capita (RGDPpc) 
(Y) 
Real GDP per capita measured in constant 2005 international 
dollars 
WDI 
DPT 
Immunization 
 Percentage of children ages 12-23 months who received DPT 
immunization before 12 months  
WDI 
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(Imm) 
Sanitation (S) Percentage of population using an improved sanitation facility WDI 
HIV prevalence 
rate (HIV) 
Estimated number of adults aged 15-49 years with HIV infection 
expressed as percent of total population in that age group 
WDI 
Urbanization 
(Urban) (U) 
Percentage of population living in areas classified as urban 
according to the criteria used by each country. 
WDI 
Population aged 
14 years and 
below (Pop1) 
Population age group below or equal to 14 years expressed as 
percentage of total population 
WDI 
Population 15-64 
years (Pop2) 
Population age group between 15 and 64 years expressed as 
percentage of total population 
WDI 
Population 65 
years and above 
(Pop3) 
Population age group above 65 years expressed as percentage of 
total population 
WDI 
Corruption Country policy and institutional Assessment (CPIA) of 
transparency, accountability and corruption in the public sector 
rating (1-low to 6=high)  
WDI 
Quality of public 
administration 
CPIA quality of public administration rating  (1=low to 6=high) WDI 
Source: Author’s compilation  
Data for the study was obtained from the World Bank world development indicators (WDI). The 
data covered the period 1995 to 2010 across 45 countries in SSA
3
. 
5.0 Results 
5.1 Determinants of health expenditure efficiency performance 
Table 2 presents Tobit model results on the effect of corruption on health expenditure efficiency 
performance. The CPIA transparency, accountability, and corruption in the public sector rating 
(1=low to 6=high) was employed as a measure of corruption. The higher the rating the better the 
                                                 
3
 The following countries were included in the study: Angola, Benin, Burkina Faso, Botswana, Burundi, Cameroon, 
Cape Verde, Central African Republic, Chad, Comoros, Congo Demographic Republic, Congo, Cote d’Ivoire, 
Equatorial Guinea, Eritrea, Ethiopia, Gabon, Ghana, Guinea, Guinea Bissau, Kenya, Lesotho, Liberia, Madagascar, 
Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, South Africa, Sao Tome, 
Senegal, Seychelles, Sierra Leone, Somalia, Sudan, Swaziland, Tanzania, The Gambia, Togo, Uganda and Zambia. 
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level of corruption in a particular country. The performance of the models and their suitability 
were reflected in the likelihood ratio (LR) chi square test for joint significance of the 
independent variables. The results in Table 6 suggest that the independent variables together are 
significant determinants of the level of efficiency of health expenditure in SSA. This can be seen 
from the highly significant chi-square test statistic at 1% significance level. 
The results show a negative relationship between improved corruption and inefficiency. This 
implies that corruption plays a critical role in determining health expenditure efficiency and 
countries with relatively improved corruption levels are likely to have better efficiency 
performance.   
HIV/AIDS was another important determinant of health expenditure efficiency. A positive and 
significant relationship was established between the variable and inefficiency in both analysis. 
This implies that countries with relatively higher HIV/AIDS burden were more likely to perform 
poorly in terms of health expenditure efficiency. A similar relationship was established by 
Alexander et al. (2003) that the proportion of adults living with HIV/AIDS negatively associates 
with efficiency. This relationship may be explained by the fact that countries with high 
prevalence of HIV usually have higher pressure on health spending and also reduced health 
outcomes.    
Table 2: Tobit model for improved corruption and health expenditure efficiency  
Variable M(UI;2IN) M(UC;2IN) M(UIC;2IN) 
Corruption -0.81109*** -0.26867** -0.30241** 
 
(0.26131) (0.11723) (0.11320) 
Immunization 0.00019 -0.00506 -0.00521 
 
(0.01219) (0.00549) (0.00529) 
GDPpc 0.00009* 0.00001 0.00001 
 
(0.00005) (0.00002) (0.00002) 
Urbanization -0.42351 -0.04132 -0.03616 
 
(0.26281) (0.12017) (0.11573) 
Population <14 -0.04607 -0.02729 -0.03443 
 
(0.09451) (0.04233) (0.04081) 
Population >65 -0.70815* -0.24275 -0.24049 
 
(0.38910) (0.17745) (0.17067) 
HIV 0.04434 0.06344*** 0.05873*** 
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(0.03274) (0.01536) (0.01476) 
Constant 9.16591* 3.61591 4.00063* 
 
(5.21557) (2.33066) (2.24721) 
LR Chi2 21.88*** 24.25*** 24.37*** 
Pseudo R2 0.1465 0.2657 0.2741 
No. of Obs. 45 45 45 
Source: Author's computation 
Note: ***significant at 1%; **significant at 5%; *significant at 10%. Standard errors are 
reported in parenthesis. M(UI;2IN): Efficiency scores from two outputs, under-five and infant 
survival rates; two inputs, HCEpc and average years of schooling. M(UC;2IN): Efficiency 
scores from two outputs, under-five and crude survival rates; two inputs, HCEpc and average 
years of schooling. M(UIC;2IN): Efficiency scores from three outputs, under-five, infant and 
crude survival rates; two inputs, HCEpc and average years of schooling. 
 
In Table 3, the relationship between health expenditure performance and public institutions was 
investigated using the Tobit model. The Country Policy and Institutional Assessment (CPIA) 
quality of public administration rating (1=low to 6=high) was used as a measure of public 
institutions quality. The higher the ranking, the better the quality of public administration. The 
results show that improved quality in public administration relates negatively with health 
expenditure inefficiency. This implies that the higher the quality of public sector administration, 
the better the performance of the health system in terms of health expenditure efficiency. This 
suggests that an important step in the bid to improve health expenditure efficiency will be to do 
that alongside improving the quality of public institutions.  
Table 3: Tobit model for Public Institutions and Health Expenditure efficiency 
Variable M(UI;2IN) M(UC;2IN) M(UIC;2IN) 
Public administration Quality -2.52359*** -0.82903** -0.88660** 
 
(0.89478) (0.37955) (0.37297) 
Immunization -0.02575* -0.01265** -0.01356** 
 
(0.01268) (0.00541) (0.00530) 
GDPpc 0.00072*** 0.00026*** 0.00026*** 
 
(0.00020) (0.00009) (0.00008) 
Urbanization -0.40428 -0.08808 -0.06154 
 
(0.27797) (0.12072) (0.11782) 
Population <14 -0.24350** -0.11260** -0.11587** 
 
(0.10148) (0.04575) (0.04416) 
Population >65 -2.23167*** -0.90765*** -0.85531*** 
 
(0.61460) (0.26088) (0.25566) 
HIV 0.04767 0.09906*** 0.08587*** 
 
(0.04183) (0.02316) (0.02129) 
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Public sector management 2.33220** 0.74094 0.76670* 
 
(1.03414) (0.43564) (0.42896) 
Constant 21.45481*** 9.09611*** 9.15508*** 
 
(5.93994) (2.60369) (2.53369) 
LR Chi2 24.24*** 31.44*** 30.05*** 
Pseudo R2 0.1989 0.4195 0.4120 
No. of Obs. 45 45 45 
Source: Author's computation 
Note: ***significant at 1%; **significant at 5%; *significant at 10%. Standard errors are 
reported in parenthesis. M(UI;2IN): Efficiency scores from two outputs, under-five and infant 
survival rates; two inputs, HEpc and average years of schooling. M(UC;2IN): Efficiency scores 
from two outputs, under-five and crude survival rates; two inputs, HEpc and average years of 
schooling. M(UIC;2IN): Efficiency scores from three outputs, under-five, infant and crude 
survival rates; two inputs, HEpc and average years of schooling  
    
Again, HIV/AIDS showed a highly significant and negative influence on efficiency. 
Immunization coverage was also found to have strong correlation with efficiency. The results 
show that countries with improved immunization coverage corresponds to better health 
expenditure efficiency performance. This result confirms the finding by Alexander et al. (2003) 
and emphasises the need for such public health programmes to be protected and improved. 
5.2 Comparative analysis of health expenditure efficiency 
Table 4 and 5 explores the efficiency performance of health systems in terms of their health 
indicators and health care spending. Countries that were estimated to be efficient were included 
in Table 4 for the analysis of best performing health systems. Considering that these countries' 
health systems have formed the benchmark for the assessment of others, it is prudent to 
investigate how their health outcomes and health expenditure compare to the regional average to 
understand the nature of efficiency. 
The table shows that nature of health  expenditure efficiency can be explained from two 
perspectives: one is the group of countries that have higher than average per capita health care 
expenditure but significantly lower than average health indicators. The second comprise a set of 
countries that have lower than average health care expenditure with corresponding better health 
outcomes. For instance, while health expenditure per capita in Mauritius and Seychelles were 
higher than the regional average, this corresponds to significantly improved health outcome 
indicators, compared to the regional averages. On the other hand, Eritrea, Ethiopia and 
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Madagascar are examples of countries with low health expenditure per capita, but health 
outcomes are relatively better than might be expected despite the scarcity of health resources. 
This explains the nature of health system efficiency in these countries.     
Table 4: Health indicators and expenditure for the best performers 
Country name HCEpc U5MR IMR LE CDR 
Cape Verde 171.69 21.30 18.20 73.92 5.37 
Eritrea 16.99 67.80 46.30 61.42 7.52 
Ethiopia 51.96 77.00 51.50 59.24 9.39 
Madagascar 39.55 61.60 42.80 66.70 6.41 
Mauritius 841.95 15.10 12.80 73.27 7.00 
Seychelles 989.37 13.80 11.90 73.46 7.40 
Regional mean 225.39 97.35 63.17 56.38 11.57 
Source: Author's computation 
Note: HCEpc= health care expenditure per capita (constant 2005 international dollar) U5MR= 
under-five mortality rate; IMR= infant mortality rate LE= life expectancy at birth; CDR= crude 
death rate 
Table 5 presents comparative analysis for the worst performing countries in terms of health 
system efficiency. The pattern of health outcomes and expenditure in these countries provide a 
clearer understanding of the nature of efficiency. The estimated efficiency scores for these 
countries lie way below the regional average. Again two group of countries can be deduced from 
the table; one group have significantly higher health expenditure above the regional average but 
this does not correspond to improved health outcomes. The other group, even though have health 
expenditure below average, their health outcomes are poorer than might be expected. 
Cameroon, Nigeria and Sierra Leone had health expenditure slightly lower than the regional 
average but the deviation of the health outcome indicators from the regional average is 
significantly large. Almost all the health outcome indicators for these countries were 
considerably poorer relative to the regional average. Swaziland and Equatorial Guinea with 
significantly higher health expenditure, relative to the regional average, performed poorly in all 
the health outcome indicators.  
A clearer observation on the nature of health expenditure efficiency can be made by comparing 
the best and worst performers. For instance, Cape Verde and Sierra Leone spend similar amounts 
on health care per capita, however, health outcome indicators for the two countries are vastly 
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different. With health expenditure per capita of $172 in Cape Verde, under-five mortality and life 
expectancy stands at 21.3 per 1000 live births and 74 years, respectively. A sharp contrast is 
observed in Sierra Leone where health expenditure per capita of about $165 correspond to under-
five mortality of 185 per 100 live births and life expectancy at birth of about 48 years. Similarly, 
health expenditure per capita in Equatorial Guinea is significantly higher than Mauritius and 
Seychelles, however, health outcome performance is significantly better in Mauritius and 
Seychelles than in Equatorial Guinea. 
Table 5: Health indicators and expenditure for the worst performers 
Country name HCEpc U5MR IMR LE CDR Eff. Score* 
Cameroon 127.92 127.20 79.20 51.58 6.00 0.26 
Nigeria 137.45 124.10 78.00 51.86 14.06 0.25 
Swaziland 433.51 103.60 69.00 48.66 14.25 0.21 
Equatorial Guinea 1642.71 118.10 79.60 51.14 14.37 0.18 
Angola 214.58 157.60 96.40 51.06 14.03 0.17 
Sierra Leone 165.24 185.30 119.20 47.78 15.34 0.15 
Regional mean 225.39 97.35 63.17 56.38 11.57 0.50 
Source: Author's computation 
Note: HCEpc= health care expenditure per capita (constant 2005 international $) U5MR= under-
five mortality rate; IMR= infant mortality rate LE= life expectancy at birth; CDR= crude death 
rate. *Efficiency scores were based on Two outputs, Under-five and Infant survival rates; Two 
inputs, HCEpc and years of schooling 
6.1 Conclusion  
The study explored health spending and outcomes in SSA, considering that the region faces high 
health challenges despite the numerous efforts to increase investments into the health systems. 
The objective of the study was to examine the efficiency of health expenditure as well as the 
effects of corruption and public sector institutions on the efficiency of health expenditure 
efficiency in SSA.  
Evidence from the DEA model show significant variation in the efficiency of health expenditure 
across countries.  This suggests significant potential for improvement in population health status 
given the current level of health resources invested into the health system. In a second stage 
analysis, the factors the explain the differences in the level of efficiency across countries were 
indentified. High corruption levels were identified as a critical limiting factor to health 
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expenditure efficiency in SSA. Also, countries with lower quality institutions were less efficient 
in using health expenditure. 
It can be concluded that, the commitment of governments to the health sector has significant 
positive impact on health expenditure efficiency. Public sector challenges such as poor quality 
public institutions and corruption should be important policy focus if improved efficiency is to 
be achieved. Effective monitoring and evaluation programmes can be established to improve the 
performance of health expenditure in the region.  
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